EICHOR
● Recruiting
Evaluation of the Safety and Performance of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in People Living With Diabetes (NEXUS)
Condition: Diabetes (Insulin-requiring, Type 1 or Type 2) · Sponsor: Medtronic MiniMed, Inc.
About this study
This study will demonstrate the safety and performance of the Novel Medtronic Experimental Automated Insulin Delivery system named MiniMed™ NMX8 system in people living with insulin-requiring diabetes in comparison with the MiniMed™ 780G system.
This description comes directly from the study's public registry record.
Talk to the study team
Renée Tillie, PhD · +31627363854 · renee.tillie@medtronic.com
Bérangère Lacroix · +41797187595 · berangere.lacroix@medtronic.com
Always discuss trial participation with your own doctor first.
Locations (9)
| Universitair Ziekenhuis Antwerpen | Antwerp, Belgium | Not Yet Recruiting |
| Cliniques Universitaires de Bruxelles - Hôpital Erasme | Brussels, Belgium | Not Yet Recruiting |
| UZ Leuven | Leuven, Belgium | Not Yet Recruiting |
| UZ Leuven | Leuven, Belgium | Not Yet Recruiting |
| Steno Diabetes Center Aarhus | Aarhus, Denmark | Not Yet Recruiting |
| Steno Diabetes Center Copenhagen | Herlev, Denmark | Not Yet Recruiting |
| Sheba Medical Center, Edmond and Lily Safra Children's Hospital | Ramat Gan, Israel | Not Yet Recruiting |
| Sheba Medical Center | Ramat Gan, Israel | Recruiting |
| University Medical Centre Ljubljana | Ljubljana, Slovenia | Not Yet Recruiting |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07227805